NICE: selecting and prioritising quality standard topics.
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing atherothrombotic events in adults with coronary or peripheral artery disease
Take an active role in producing a NICE guideline or quality standard.
Evidence-based recommendations on lanadelumab (Takhzyro) for preventing recurrent attacks of hereditary angioedema in people aged 12 and over
Evidence-based recommendations on midcarpal hemiarthroplasty (using a metal implant to create an artificial wrist joint) for wrist arthritis in adults
Please complete all the required fields before submitting the form. Sign up to receive email updates on interventional
NICE board strategy meeting papers
Information for developers of digital therapies about submitting a product to the IAPT programme
Jobs at NICE. Includes current vacancies, roles, location and salary information.
Provider grid Details of the Content Resources and services offered by appointed Providers under the NICE Electronic and Print Content Framework....
This guideline covers organising and delivering end of life care services, which provide care and support in the final weeks and months of life (or for some conditions, years), and the planning and preparation for this. It aims to ensure that people have access to the care that they want and need in all care settings. It also includes advice on services for carers.
Everything NICE has said on assessing and managing recent suspected cardiac chest pain including acute coronary syndromes and stable angina in an interactive flowchart
Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart
Everything NICE has said on cardiac rehabilitation and preventing cardiovascular disease after myocardial infarction in an interactive flowchart
Our position on use of the EQ-5D-5L valuation set for England
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart
Everything NICE has said on blood and immune system conditions in an interactive flowchart
Everything NICE has said about the care of people with a progressive life-limiting condition who are at the end of their life in an interactive flowchart
Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.
Everything NICE has said on managing violence in mental health, health and community settings in an interactive flowchart
Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart
The information below provides a summary of known issues and upcoming changes related to NICE Evidence Services. This information will be updated...
This guidance evaluates new, innovative medical devices and diagnostics. It looks at medical technologies that: deliver treatment - like those...
Advice on the use of MR-proADM test for use with clinical deterioration scores in cases of suspected infection to aid local decision making
Advice on the use of superDimension Navigation System to help diagnostic sampling of peripheral lung lesions to aid local decision making
An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE for use in the Cancer Drugs Fund (CDF).
How to apply to become the new chief executive of NICE
Find out more about the NICE Medical Technologies Advisory Committee members by reading their biographies. Professor Peter Groves Chair About
Details, meeting dates and minutes of the independent technology appraisal committees
Information, meeting dates and minutes of the medical technologies advisory committee
How we select the subjects for development into information, advice and guidance
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart
Everything NICE has said on harmful sexual behaviour among children and young people (under 18s or under 25s with special educational needs or a disability) in an interactive flowchart.
Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart
Biographies of the NICE senior management team and minutes of their meetings
This guideline covers diagnosing and managing gastro-oesophageal reflux disease in children and young people (under 18s). It aims to raise awareness of symptoms that need investigating and treating, and to reassure parents and carers that regurgitation is common in infants under 1 year.
Evidence-based recommendations on Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea (excessive salivation and drooling) in adults
Everything NICE has said on cerebral palsy in an interactive flowchart
Everything NICE has said on eye conditions in an interactive flowchart
Everything NICE has said on diagnosing and managing Parkinson's disease in adults in primary and secondary care in an interactive flowchart
Everything NICE has said on assessing and managing motor neurone disease in adults in an interactive flowchart
Evidence-based recommendations on the EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing
Everything NICE has said on musculoskeletal conditions in an interactive flowchart
NICE quality standards set out priority areas for quality improvement in health and social care.
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the fast track appraisal.